03.01.2005 23:19:00

Inamed to Present at 23rd Annual JPMorgan Healthcare Conference; Monda

Inamed to Present at 23rd Annual JPMorgan Healthcare Conference; Monday, January 10, 2005, at 2:00 p.m. PST


    Business Editors/Health/Medical Writers
    JPMorgan Annual Healthcare Conference 2005

    SANTA BARBARA, Calif.--(BUSINESS WIRE)--Jan. 3, 2005--Inamed Corporation (Nasdaq:IMDC), a global healthcare company, today announced that Chairman, President & Chief Executive Officer Nick Teti will be presenting at the 23rd Annual JPMorgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco on Monday, January 10, 2005, at 2:00 p.m. PST.

    Live Audio Webcast

    Interested parties can access a live audio webcast of the presentation through the following link: www.inamed.com.

    Internet Replay

    An audio replay of the presentation will be available at www.inamed.com for two weeks after the presentation. In addition, a copy of the presentation will also be available beginning three hours after the presentation on the Inamed Corporation website, www.inamed.com.

    About Inamed Corporation

    Inamed (Nasdaq:IMDC) is a global healthcare company with over 25 years of experience developing, manufacturing and marketing innovative, high-quality, science-based products. Current products include breast implants for aesthetic augmentation and for reconstructive surgery; a range of dermal products to treat facial wrinkles; and minimally invasive devices for obesity intervention, including the LAP-BAND(R) System for morbid obesity. The Company's website is www.inamed.com.

--30--SW/la*

CONTACT: Inamed Corporation Dan Cohen, Vice President Global Corporate and Government Affairs 202-638-4179 (o) 202-329-1825 (c)

KEYWORD: CALIFORNIA INDUSTRY KEYWORD: MEDICAL MEDICAL DEVICES TRADESHOW CONFERENCE CALLS SOURCE: Inamed Corporation

Copyright Business Wire 2005

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Nachrichten zu INAMED Corp.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu INAMED Corp.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Indizes in diesem Artikel

NASDAQ Comp. 19 954,30 -0,50%
S&P 600 SmallCap 935,46 -0,94%